Routine proxy reminder, no trading signal. Monitor for any dissident activity or vote results post-June 17 meeting. The officer exculpation amendment is standard governance but could see opposition from governance-focused investors.
CRBU drugs
CRBU drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Jun 8 $1.84entry
- T+1 · 5mo ago 0.00%α +0.29% · $1.84
- T+5 · 5mo ago −9.78%α −11.89% · $1.66
- T+20 · 4mo ago −0.54%α −2.17% · $1.83
- T+60 · due 3mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Caribou Biosciences filed a DEFA14A urging stockholders to vote ahead of the June 17, 2026 annual meeting. The board recommends voting FOR director elections, auditor ratification, an officer exculpation charter amendment, and an adjournment proposal. This is a routine solicitation reminder with no new financial or strategic information.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for June 17, 2026
- Board recommends voting FOR all four proposals: Class II director election, Deloitte ratification, officer exculpation amendment, and adjournment proposal
- Filing is a reminder to vote, no new material information disclosed
- D.F. King & Co. assisting with proxy solicitation
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- Low shareholder turnout could delay or fail the officer exculpation proposal
- No dissident or activist context in this filing, risk of unexpected opposition is minimal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001619856-26-000039 |
| Document: 0001619856-26-000039-index-headers.html | 0001619856-26-000039 |
| Document: 0001619856-26-000039-index.html | 0001619856-26-000039 |
| Document: 0001619856-26-000039.txt | 0001619856-26-000039 |
Track record
13 reports on CRBU
3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +28.02% at T+20 after the Oct 6, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Bearish 7/10 Entry $0.4487 Now $0.3530 +21.33% settles Dec 7
- Oct 6, 20265w ago 8-K Bearish 7/10 Entry $0.6174 to $0.4444 Now $0.3530 +42.82% ▲ +28.02% +26.68% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $1.34 to $0.5190 Now $0.3530 −73.66% ▼ −61.27% −60.71% vs SPY
- Jun 11, 202622w ago 8-K Bullish 6/10 Entry $1.66 to $1.94 Now $0.3530 −78.73% ▲ +16.87% +14.98% vs SPY
- Jun 11, 202622w ago Press Release Bullish 7/10 Entry $1.66 to $1.94 Now $0.3530 −78.73% ▲ +16.87% +14.98% vs SPY
- Jun 5, 202623w ago DEFA14A Neutral 2/10 Viewing Entry $1.84 to $1.83 Now $0.3530 −80.82% ▼ −0.54% −2.17% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $2.13 to $2.16 Now $0.3530 −83.43% ▲ +1.41% −3.55% vs SPY
- Mar 5, 202636w ago 8-K Mixed 5/10 Entry $1.82 to $1.95 Now $0.3530 −80.60% ▲ +7.14% +9.19% vs SPY
- Mar 5, 202636w ago Press Release Mixed 6/10 Entry $1.82 to $1.95 Now $0.3530 −80.60% ▲ +7.14% +9.19% vs SPY
- Feb 28, 202637w ago Institutional Cluster Neutral 5/10 Entry $1.84 to $1.72 Now $0.3530 −80.82% ▼ −6.52% +1.42% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers